Interest of the Immunoscore® as a Post-operative Complementary Tool for the Detection of the Risk of Recurrence in Patients With Nonmetastatic Colorectal Cancer
Recruiting · NCT04938986 · Interventional (participants receive a specific treatment) · Lead sponsor: Hospital St. Joseph, Marseille, France
View the official record on ClinicalTrials.gov →Interventions studied
IMMUNOSCORE®
What this trial is about
Evaluate the patient care recommandation induced by the IMMUNOSCORE® result
Who can take part
Age range
18 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- age between 18 and 80 inclusive;
- histologically confirmed colon adenocarcinoma;
- having undergone a curative resection of stage I, II or III colorectal cancer;
- diagnosed T1 / T2 / T3 / T4 and N0 / N1 / N2;
- eligible to receive 6 months of adjuvant chemotherapy;
- having given free, informed and written consent;
- agreeing to the use of a tumor sample for research purposes;
- being affiliated to a social security system.
Exclusion criteria
- pregnant or breastfeeding women
- legal incapacity or physical, psychological, social or geographical conditions preventing the patient from signing the consent or completing the study.
- history of other solid tumor within 3 years before inclusion, with the exception of in-situ cancer of the cervix and skin cancers (basal or squamous) treated and controlled
- person subject to a safeguard measure.
Where it is running
2 locations listed.
- Hôpital Européen - Marseille, France
- Hopital Saint Joseph - Marseille, France